Ascension | St. Clair Nephrology Research
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney disease.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Other protocol defined Inclusion/Exclusion criteria apply.
Primary purpose
Allocation
Interventional model
Masking
466 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Medical Information
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal